Categories: Tech

Constellation Software Inc. Announces Conference Call

 | Source: Constellation Software Inc.

TORONTO, Sept. 26, 2025 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) (“Constellation” or “CSI”) announced today its President, Mark Miller, and its Chief Financial Officer, Jamal Baksh, will host a live shareholder question and answer audio webcast on October 1st, 2025 at 2:30 p.m. ET to discuss the transition of Constellation’s leadership from Mark Leonard to Mark Miller.

To access the call, please dial 1-877-879-1183 (North America toll free) or 1-412-902-6703 (International) and using conference ID 4557595.  A conference operator will create a queue and introduce each questioner.  You can also hear the call using the link https://edge.media-server.com/mmc/p/r8bx6qbj.  A replay of the call can be accessed using the link https://edge.media-server.com/mmc/p/r8bx6qbj for 12 months following the call.

About Constellation Software Inc.

Constellation’s common shares are listed on the Toronto Stock Exchange under the symbol “CSU”. Constellation Software acquires, manages and builds vertical market software businesses.

For further information:

Jamal Baksh
Chief Financial Officer
416-861-9677
info@csisoftware.com
www.csisoftware.com

GlobeNews Wire

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

19 hours ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

6 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago